Clinical Trials · NCT07682818

Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic Function

Name: Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic Function
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

RecruitingPhase 1Petrelintide

Phase: Phase 1
Recruitment status: Recruiting
Sponsor: Zealand Pharma
Enrollment: 36
Start date: May 2026
Locations: 3 sites, Poland, Slovakia
Primary endpoint: Area Under the Plasma Concentration-time Curve (AUC) from Time Zero to Infinity (AUC0-inf) of Petrelintide

View Petrelintide compound reference